Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
15.23B | 14.89B | 15.62B | 16.67B | 13.80B | 16.38B | Gross Profit |
6.28B | 5.78B | 5.36B | 6.64B | 4.71B | 6.13B | EBIT |
1.08B | 622.00M | -69.00M | 1.14B | -862.00M | 574.00M | EBITDA |
1.67B | 1.17B | 489.43M | 994.00M | -403.00M | 1.16B | Net Income Common Stockholders |
823.00M | 502.00M | -202.00M | 256.00M | -665.00M | 351.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.22B | 1.87B | 1.22B | 877.00M | 2.40B | 1.65B | Total Assets |
11.85B | 11.04B | 11.39B | 12.76B | 13.77B | 13.68B | Total Debt |
5.47B | 5.44B | 6.02B | 6.25B | 7.66B | 7.68B | Net Debt |
3.50B | 3.57B | 4.80B | 5.37B | 5.68B | 6.31B | Total Liabilities |
8.72B | 8.45B | 9.15B | 10.04B | 11.15B | 10.36B | Stockholders Equity |
3.13B | 2.60B | 2.23B | 2.72B | 2.61B | 3.32B |
Cash Flow | Free Cash Flow | ||||
1.11B | 1.11B | -78.00M | 115.00M | -155.00M | 366.00M | Operating Cash Flow |
1.57B | 1.53B | 607.00M | 809.00M | 237.00M | 1.41B | Investing Cash Flow |
-707.00M | -334.00M | -227.00M | -446.00M | -510.00M | -894.00M | Financing Cash Flow |
-244.00M | -567.00M | 6.00M | -1.47B | 895.00M | -560.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $4.84B | 8.64 | 50.86% | ― | 19.59% | 154.53% | |
80 Outperform | $5.24B | 13.30 | 14.02% | ― | 7.71% | 40.01% | |
79 Outperform | $4.99B | 14.97 | 7.53% | 0.15% | ― | ― | |
71 Outperform | $7.58B | 9.34 | 26.25% | 2.99% | 2.70% | 1900.36% | |
69 Neutral | $2.30B | 10.27 | 13.25% | 4.17% | 6.38% | 6.08% | |
67 Neutral | $4.00B | 13.94 | 29.58% | 3.13% | 3.57% | 120.60% | |
60 Neutral | $13.01B | 10.45 | 0.79% | 3.53% | 1.60% | -22.47% |